| Federal Response Blog Posts | |
| Substance Misuse, Infectious Disease, and the Powerful Potential of Syringe Service Programs | |
| Health and Human Services Assistant Secretary for Health ADM Brett Giroir discusses the proven ability of syringe service programs to help combat the opioid crisis and prevent the spread of infectious disease linked to injection drug use. He invites stakeholders to join the Syringe Services Programs – A Critical Public Health Intervention webinar on November 21 from 2:00 - 3:15 PM (ET). | |
| |
| PrEP Program Webinar: Next Week/Register Now | |
| Please register for a webinar on the new HHS pre-exposure prophylaxis (PrEP) program that makes PrEP available to those without prescription drug coverage who can benefit from using PrEP. | |
|
| United States Files Patent Infringement Lawsuit Against Gilead Related to Truvada® and Descovy® for Pre-exposure Prophylaxis of HIV | |
| Wednesday, the United States, on behalf of the Department of Health and Human Services, filed a complaint in federal district court against Gilead Sciences, Inc. and Gilead Sciences Ireland UC (collectively, Gilead) seeking damages for Gilead’s infringement of HHS patents related to pre-exposure prophylaxis (or PrEP) for HIV prevention. | |
|
| The 2020 Health Insurance Marketplace Is Open for Business! | |
| You can apply for new 2020 health insurance, or renew, change, or update your 2019 health plan for 2020. Make sure you sign up by the December 15 deadline. Find more information and resources in this week's blog. | |
|
No hay comentarios:
Publicar un comentario